In parallel to OICR-9429 treatment, α-SMA and Slug expression levels diminished in intermittent hyperglycemia-exposed EC where MLL2 was knocked down in comparison to only intermittent high-glucose-treated EC (Figure 6B). The gene discussed is SNAI2; the disease is Hyperglycemia.